Clinical Trials Logo

Enterocolitis, Necrotizing clinical trials

View clinical trials related to Enterocolitis, Necrotizing.

Filter by:

NCT ID: NCT00392977 Completed - Clinical trials for Necrotizing Enterocolitis

Brain Manganese Deposition in High Risk Neonates

Start date: August 2006
Phase: N/A
Study type: Observational

Excessive exposure to manganese (Mn) results in Mn deposition in the brain causing adverse neurological effects. Sick infants requiring parenteral nutrition (PN) may be at increased risk of Mn neurotoxicity because neonatal PN solutions contain high concentrations of Mn. This proposal will investigate brain deposition of Mn, a paramagnetic element, by magnetic resonance (MR) imaging in preterm and term neonates receiving Mn-supplemented PN and gestational age-matched control infants. The goals of this project are to identify neonatal populations that are at increased risk of excessive brain Mn deposition based on their gestational age, iron status, hepatic function and dietary Mn intake, and to make evidence-based recommendations for appropriate Mn supplementation and monitoring of infants receiving PN.

NCT ID: NCT00392730 Completed - Clinical trials for Necrotizing Enterocolitis

Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children

Start date: August 2006
Phase: N/A
Study type: Observational

Manganese (Mn) is an essential metal required for normal growth and development. However, exposure to high Mn levels can be toxic to the brain. The objectives of this project are to identify neonatal and young pediatric populations that are at increased risk of excessive brain Mn deposition and altered cognitive and motor development based on their dietary parenteral Mn exposure, and to make sound and evidence-based recommendations for appropriate Mn supplementation and monitoring of infants and young children receiving parenteral nutrition (PN). Our studies are designed to test the hypotheses that, compared with unexposed age-matched controls, infants and young children receiving prolonged Mn-supplemented PN will have increased deposition of Mn in their brains and lower scores on neurodevelopmental, cognitive and psychophysiological assessments.

NCT ID: NCT00332592 Completed - Clinical trials for Necrotizing Enterocolitis

Intragastric and Peritoneal Microdialysis in Infants With Necrotizing Enterocolitis (NEC)

Start date: October 2006
Phase: Phase 4
Study type: Observational

NEC is a serious inflammatory bowel disease, which almost only strikes infants with low birth weight and low gestational age. The morbidity and mortality rates are high, and early diagnosis and treatment is mandatory. The primary aim of the present study is to investigate the clinical use of intragastric microdialysis and whether it is able to select patients, who may benefit from either medical or surgical therapy. The aim of intraperitoneal microdialysis is to evaluate whether changes in intraperitoneal microdialysis reflect the clinical outcome after laparotomy.

NCT ID: NCT00315263 Completed - Respiratory Failure Clinical Trials

Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology

Start date: April 2006
Phase: N/A
Study type: Observational

This research seeks to establish a neonatal DNA Tissue Bank to find out if differences in small segments of DNA predispose babies to Chronic Lung Disease (CLD), Periventricular Brain Injury (PVI), Necrotizing Enterocolitis (NEC), or Hypoxic Respiratory Failure (HRF).

NCT ID: NCT00252681 Completed - Clinical trials for Necrotizing Enterocolitis

Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human Infants

Start date: July 1999
Phase: N/A
Study type: Interventional

The primary purpose of this study is to compare two surgical treatments for perforated necrotizing enterocolitis in very low birth weight babies.

NCT ID: NCT00059449 Completed - Premature Birth Clinical Trials

Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis

Start date: n/a
Phase: N/A
Study type: Observational

Necrotizing enterocolitis (NEC) is a serious gastrointestinal disorder that primarily affects preterm infants. About 10% of babies less than 32 weeks gestation at birth will develop it. Overall, 30% of babies who develop NEC will die from it, with many others developing long term gastrointestinal problems. The most important factor in its development is a premature intestinal tract. Epidermal growth factor (EGF) is an important growth factor in the development and maintenance of the gastrointestinal tract. This study will look for a relationship between EGF levels in premature babies and the development of NEC.

NCT ID: NCT00005888 Completed - Sepsis Clinical Trials

Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants

Start date: January 1997
Phase: N/A
Study type: Interventional

OBJECTIVES: I. Compare the incidence of late onset sepsis and/or necrotizing enterocolitis and duration of hospitalization in low birth weight infants fed with fortified mother's milk supplemented with either fortified pasteurized donor human milk or preterm formula, and with fortified mother's milk versus preterm formula. II. Determine the relationship between functional antibody titers in serial milk samples and the incidence of pathogen specific late onset sepsis (e.g., Staphylococcus epidermidis, Staphylococcus aureus) in these patients. III. Determine the long term sequelae (growth, body composition, health, and neurodevelopment) of human milk versus formula feeding in these patients. IV. Determine the relationship between stress and milk production in the mothers of these patients.